GT
ZBH icon

Greenleaf Trust’s Zimmer Biomet ZBH Stock Holding History

Greenleaf Trust’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,231
Closed -$203K – 844
2025
Q2 		$203K Sell
2,231
-2,612
-54% -$253K ﹤0.01% 765
2025
Q1 		$548K Sell
4,843
-65
-1% -$6.95K 0.01% 475
2024
Q4 		$518K Buy
4,908
+863
+21% +$92.6K ﹤0.01% 496
2024
Q3 		$437K Sell
4,045
-1,227
-23% -$134K ﹤0.01% 546
2024
Q2 		$572K Buy
5,272
+316
+6% +$37.3K 0.01% 447
2024
Q1 		$654K Sell
4,956
-163
-3% -$20.4K 0.01% 401
2023
Q4 		$623K Sell
5,119
-1,260
-20% -$141K 0.01% 399
2023
Q3 		$716K Sell
6,379
-469
-7% -$59.6K 0.01% 337
2023
Q2 		$997K Sell
6,848
-232
-3% -$31.5K 0.01% 275
2023
Q1 		$915K Buy
7,080
+644
+10% +$80.9K 0.01% 300
2022
Q4 		$821K Buy
6,436
+280
+5% +$32.5K 0.01% 312
2022
Q3 		$644K Buy
6,156
+1,792
+41% +$197K 0.01% 340
2022
Q2 		$458K Buy
4,364
+1,341
+44% +$159K 0.01% 424
2022
Q1 		$387K Sell
3,023
-242
-7% -$29.2K ﹤0.01% 497
2021
Q4 		$403K Sell
3,265
-149
-4% -$19.5K ﹤0.01% 496
2021
Q3 		$485K Sell
3,414
-722
-17% -$106K 0.01% 402
2021
Q2 		$646K Buy
4,136
+135
+3% +$21.9K 0.01% 328
2021
Q1 		$622K Buy
4,001
+568
+17% +$88K 0.01% 319
2020
Q4 		$514K Buy
3,433
+209
+6% +$29.5K 0.01% 331
2020
Q3 		$426K Buy
3,224
+170
+6% +$22.2K 0.01% 327
2020
Q2 		$354K Buy
3,054
+503
+20% +$58K 0.01% 368
2020
Q1 		$250K Buy
2,551
+1,163
+84% +$152K 0.01% 372
2019
Q4 		$202K Buy
+1,388
New +$192K ﹤0.01% 522
2017
Q4 		– Sell
-11
Closed -$1K – 716
2017
Q3 		$1K Buy
+11
New +$1.27K ﹤0.01% 698

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Greenleaf Trust's ZBH Position: Q3 2025 in Review

Greenleaf Trust sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 2,231 shares — an estimated $203K sold.

Greenleaf Trust first reported a position in ZBH in Q3 2017 and held it in 24 quarters. The position peaked at $997K in Q2 2023. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.

  • Greenleaf Trust reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
  • Greenleaf Trust sold 2,231 Zimmer Biomet shares in Q3 2025, an estimated $203K.
  • Greenleaf Trust first reported a position in Zimmer Biomet in Q3 2017 and held it in 24 quarters.
  • Greenleaf Trust's Zimmer Biomet position peaked at $997K in Q2 2023.
  • 966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.

Based on Greenleaf Trust's 13F filing for Q3 2025, filed 22 Oct 2025.